Frontotemporal dementia represents a group of clinical syndromes that specifically target language, behavior, social, and motor systems. The overarching goals of this Program Project Grant have been to detail the pathologic, genetic, imaging, cognitive, emotional, and behavioral features of these syndromes. In this renewal application, the Administrative and Clinical Core continues to maintain the PPG's overall administrative infrastructure and provide well characterized subjects and biospecimens to the PPG Projects and other Cores.
Our specific aims are to recruit patients with bvFTD (n=90), svPPA (n=40), nfvPPA (n=30), lvPPA (n=30), non- language AD (n=30), CBS/PSP (n=30), asymptomatic mutation carriers (n=20), major depressive disorder (n=100), bipolar disease (n=100), and normal controls (n=15), engage in deep behavioral phenotyping, follow subjects annually, obtain autopsy consent, integrate evaluation data with the Imaging, Genetics, and Neuropathology/Biospecimen Cores, and refer subjects to the individual, hypothesis-driven PPG Projects.

Public Health Relevance

The overarching goals of this Program Project Grant are to further detail the pathologic, genetic, imaging, cognitive, emotional, and behavioral features of the frontotemporal dementias. Project goals include providing tools for better differential diagnosis, understanding disease progression along anatomical networks, and defining non-language changes in the progressive aphasia. The aims of this Administrative and Clinic Core are to recruit and evaluate subjects, refer subjects to the Projects and other Cores, and provide the overall PPG scientific, administrative and budgetary infrastructure.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
5P01AG019724-19
Application #
9949600
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
2020-06-01
Budget End
2021-05-31
Support Year
19
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Type
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94118
Miller, Zachary A; Rosenberg, Lynne; Santos-Santos, Miguel A et al. (2018) Prevalence of Mathematical and Visuospatial Learning Disabilities in Patients With Posterior Cortical Atrophy. JAMA Neurol 75:728-737
Rojas, Julio C; Stephens, Melanie L; Rabinovici, Gil D et al. (2018) Multiproteinopathy, neurodegeneration and old age: a case study. Neurocase 24:1-6
Dijkstra, Anke A; Lin, Li-Chun; Nana, Alissa L et al. (2018) Von Economo Neurons and Fork Cells: A Neurochemical Signature Linked to Monoaminergic Function. Cereb Cortex 28:131-144
Mok, Sue-Ann; Condello, Carlo; Freilich, Rebecca et al. (2018) Mapping interactions with the chaperone network reveals factors that protect against tau aggregation. Nat Struct Mol Biol 25:384-393
Erkkinen, Michael G; Zúñiga, Raquel Gutiérrez; Pardo, Cristóbal Carnero et al. (2018) Artistic Renaissance in Frontotemporal Dementia. JAMA 319:1304-1306
Schneider, Raphael; McKeever, Paul; Kim, TaeHyung et al. (2018) Downregulation of exosomal miR-204-5p and miR-632 as a biomarker for FTD: a GENFI study. J Neurol Neurosurg Psychiatry 89:851-858
Ljubenkov, Peter A; Staffaroni, Adam M; Rojas, Julio C et al. (2018) Cerebrospinal fluid biomarkers predict frontotemporal dementia trajectory. Ann Clin Transl Neurol 5:1250-1263
La Joie, Renaud; Bejanin, Alexandre; Fagan, Anne M et al. (2018) Associations between [18F]AV1451 tau PET and CSF measures of tau pathology in a clinical sample. Neurology 90:e282-e290
Kim, Eun-Joo; Brown, Jesse A; Deng, Jersey et al. (2018) Mixed TDP-43 proteinopathy and tauopathy in frontotemporal lobar degeneration: nine case series. J Neurol 265:2960-2971
Henry, Maya L; Hubbard, H Isabel; Grasso, Stephanie M et al. (2018) Retraining speech production and fluency in non-fluent/agrammatic primary progressive aphasia. Brain 141:1799-1814

Showing the most recent 10 out of 607 publications